Pharmacokinetics of eugenol and its effects on thermal hypersensitivity in rats
详细信息 查看全文
- 作者：Sarah Annie Gué ; nette ; André ; anne Ross ; Jean-Francois Marier ; Francis Beaudry ; Pascal Vachon
- 关键词：Eugenol ; Neuropathic pain ; Hyperalgesia and allodynia ; Sprague– ; Dawley rats
- 刊名：European Journal of Pharmacology
- 出版年：2007
- 出版时间：7 May 2007
- 年：2007
- 卷：562
- 期：1-2
- 页码：60-67
- 全文大小：298 K
文摘
Neuropathic pain is a type of chronic pain following central or peripheral nervous system lesions that cause allodynia (pain initiated by a non-painful stimulus) and hyperalgesia (increased pain sensation following a painful stimulus). The first objective of the study was to evaluate the pharmacokinetics of eugenol, the principle chemical constituent of clove oil, following a gavage administration (40 mg/kg) in male Sprague–Dawley rats. The second objective was to evaluate the effect of repeated oral administrations of eugenol on hyperalgesia and allodynia using an experimental model of neuropathic pain in rats. Thermal and mechanical sensitivity (Hargreave's test and von Frey filaments) were determined in sciatic nerve cuff-implanted rats. Sensitivities were assessed following repeated oral administrations of 40 mg/kg of eugenol or saline for 5 days (n = 6 per group). Pharmacokinetic parameters were calculated using noncompartmental methods. Serial blood samples were collected over 24 h. Concentrations of eugenol in blood and plasma peaked rapidly following oral administration. Mean T1/2 values of eugenol in plasma and blood were long (14.0 and 18.3 h, respectively), suggesting a potential accumulation of the drug following repeated administrations. Reaction time to thermal stimuli appeared to increase constantly following repeated administrations of eugenol. On the last day of treatment, eugenol treatments resulted in a statistically significant prolongation of the reaction time to thermal stimuli in rats compared to the saline group (Mean ± S.E.M.: 11.4 ± 1.23 vs. 6.1 ± 0.53 s, P < 0.01). These results support the hypothesis that eugenol may alleviate neuropathic pain and that the cumulative effect of the drug may be in part responsible for this effect following repeated daily administrations.